Assessment 1: Proposing Evidence Based Change

1

Change Proposal Summary Report

Jessica Ramos

Capella University

FPX 6218: Leading the Future of Health Care

Dr. Donna Ryan

November 24, 2021

2

Change Proposal Summary Report

One of the clinical conditions affecting numerous people globally is diabetes. Around 35

million people in the United States are diagnosed with diabetes annually. Based on the world

statistics, diabetes pervasiveness has increased promptly among people of low and middle

incomes. Accordingly, people living in countries such as India and China have the highest

prevalence of diabetes. Globally, approximately 5.0 million deaths resulted from diabetes and

diabetes-related disorders. Again, the countries spend billions of dollars on health expenditures for

diabetic patients and other approaches to minimize its prevalence through education and other

evidence-based practices. Besides, more than 400 million people globally are likely to develop

type 2 diabetes mellitus. The executive summary will describe some of the challenges facing

healthcare, such as type 2 diabetes, and ideal strategies and measures to mitigate such health issues.

Executive Summary

Proposed Change

Globally, type 2 diabetes mellitus is a chronic health issue affecting numerous people.

From statistics, persons diagnosed with the disease have increased significantly in the past few

decades. The Center for Disease Control has pointed out a high incidence of type 2 diabetes

mellitus among children, the elderly, and teenagers (Mayer-Davis et al., 2017). Some of the risk

factors aligned with diabetes mellitus encompass behavioral practices, lifestyle, and genetics. A

proposed change to lessen the prevalence of type 2 diabetes mellitus entails implementing

programs including the Lifestyle Change Program and Diabetes Management Education and

Support (DMES). Such a proposed change will play a central role in raising awareness and giving

people critical information regarding type 2 diabetes, its prevention, and management (Munshi et

al., 2016). From contemporary clinical studies, recognizing diabetes risk factors early is crucial in

3

preventing and managing chronic disorders (American Diabetes Association, 2016). Efficient

therapy might prevent or precisely delay diabetic complications. Thus, the DMES program

educates people regarding diabetes, preventive, and management strategies to improve their

lifestyle and behavioral practices.

Desired Outcomes

There is a need to boost awareness of various risk factors aligned with type 2 diabetes

mellitus. Many people will understand the risk factors contributing to the clinical disorder and

various measures or strategies to reduce its prevalence through the proposed programs (Munshi et

al., 2016). Understanding and managing the clinical condition effectively will significantly reduce

the global mortality rate associated with diabetes (American Diabetes Association, 2016).

Additionally, the program will educate people on the best behavioral practices and lifestyles to

reduce their exposure to risk factors leading to increased death rates.

Essentially, type 2 diabetes mellitus patients should be taught the best mitigating measures

to minimize mortality rates and boost life quality by adopting ideal lifestyles. To adequately

address this clinical condition, it is imperative to know its prevalence, the people's access to health

and education facilities, and the existence of health insurance cover (Stevens et al., 2015). These

desired outcomes will give the cornerstone for implementing the proposed change to address type

2 diabetes prevalence (American Diabetes Association, 2016). The federal government, personal

savings, and insurance firms (insured) will pay for the care. However, some factors might limit the

accomplishment of these outcomes, such as lack of resources needed for care, general

misunderstanding regarding the seriousness of the disorder, and poverty among people living in

low-income countries.

4

Health Care System Comparative Analysis

The United States is one of the countries with well-developed healthcare systems to address

the issue of type 2 diabetes mellitus (Stevens et al., 2015). Ideally, the U.S. healthcare system has

healthcare programs and reforms to improve disease prevention and management compared to

China and India (American Diabetes Association, 2016). For instance, America has numerous

health insurance covers for diabetic patients, increased access to education or health services, and

health promotion initiatives to minimize the prevalence of diabetes mellitus.

Rationale for the Proposed Change

According to statistics, type 2 diabetes is among the leading contributors of death among

Americans. Indeed, there is a close correlation between diabetic Mellitus and other disorders,

including cardiovascular ailments and kidney-interrelated diseases. The World Health

Organization (WHO) has depicted that the worldwide frequency of type 2 diabetes is anticipated to

reach more than 500 million in the coming years (Mayer-Davis et al., 2017). There is a need for the

federal government and private agencies to implement measures for promoting early detection

through appropriate screening, lifestyle and behavioral change, and management strategies for

patients diagnosed with the ailment (Stevens et al., 2015). The proposed change would educate

people on prevention and management policies for diabetes.

Financial and Health Implications

Based on the American Diabetes Association, the total cost for treating diabetes is

approximately $350 billion annually. Some of the expenditure goes to the medication, while the

rest is associated with productivity loss in the working patients. Implementing the proposed

changes is imperative since the overall cost aligned with treating and managing diabetic patients is

5

comparatively higher than planning and designing the preventive approaches (American Diabetes

Association, 2016). Failure to make changes will lead to higher expenditures on treatment and

management plans and high mortality and morbidity rates related to diabetes mellitus.

Conclusion

The proposed change will play an integral purpose in reducing the overall prevalence of

diabetes in various regions of the world. The strategies will raise awareness and give people critical

information regarding type 2 diabetes, prevention, and management. In actuality, they will educate

them regarding diabetes, preventive and management strategies to improve their lifestyle, and

behavioral practices (Munshi et al., 2016). Early detection of the clinical condition primarily

through efficient therapy and screening will prevent or precisely delay diabetic complications.

Thus, it will also reduce the billions of dollars spent in healthcare organizations addressing diabetes

mellitus, and the high mortality and morbidity rates reported globally.

SUMMARY REPORT 6

Appendix

Table 1: Health Care System Comparative Analysis

Table directions:

1. Add the names of the two non-U.S. health care systems and the local or regional U.S. health care system to the applicable column

headings.

2. In the first column, list each outcome. Add rows to your table, as needed.

3. Add the relevant information pertaining to each outcome for each health care system in the second, third, and fourth columns.

7

Outcomes [Health Care System 1]-

(China) [Health Care System 2]

(India) [U.S. Health Care System]

The pervasiveness of type 2

diabetes mellitus.

The type 2 diabetes prevalence

rate is approximately 12.5%

and is expressively increasing.

The type 2 diabetes mellitus

prevalence in the country is

around 12.0%.

The type 2 diabetes mellitus

prevalence in the state is

around 10 percent (Stevens et

al., 2015). The number of

Americans with the disorder

has increased in the past

decade, making it a pandemic

and necessitating instant

preventive measures.

8

Outcomes [Health Care System 1]-

(China) [Health Care System 2]

(India) [U.S. Health Care System]

Health and Education Access. There is poor or inadequate

access to healthcare and

education services for self-care

or personal management of the

chronic disorder (Munshi et al.,

2016). There is a lack of

community engagement and

efficient measures to prevent

and manage type 2 diabetes

mellitus.

Inadequate education and

health access create a barrier to

quality care services and

appropriate preventive

approaches for the clinical

condition such as screening

(A1c testing). Lack of

comprehensive care hinders

measures to curb the increasing

incidences of type 2 diabetes

(Munshi et al., 2016). Low or

poor lifestyles contribute to

rising cases of the disorder.

Multiple regions in America

have access to quality care and

education services on the

prevention of diabetes (Stevens

et al., 2015). Many training

programs, interventions, and

continuous education facilities

for patients on diabetic risk

factors have reduced its

prevalence and fatality.

9

Outcomes [Health Care System 1]-

(China) [Health Care System 2]

(India) [U.S. Health Care System]

Health Insurance Coverage. The federal government in the

country does not prioritize the

type 2 diabetes epidemic

contributing to increased care

costs for diabetic patients (Li,

et al., 2020). The prevention,

treatment, and management

cost of the disease is relatively

high.

The federal government gives

subsidies for diabetes

prevention, management, and

treatment. But, there is no

organizational assistance to

fully cover the treatment

procedures for diabetic patients

where they pay most of the

care cost.

There are well-designed

insurance firms such as

Medicare and Medicaid that

provide medical coverage

incentives for diabetic patients

who qualify for the programs

(Stevens et al., 2015). The cost

of care for the insured patients

is relatively low or free,

depending on their

qualifications and terms of care

services.

Running head: SUMMARY REPORT 10

References

American Diabetes Association. (2016). 1. Strategies for improving care. Diabetes

care, 39(Supplement 1), S6-S12.

Li, Y., Teng, D., Shi, X., Qin, G., Qin, Y., Quan, H., ... & Shan, Z. (2020). Prevalence of diabetes

recorded in mainland China using 2018 diagnostic criteria from the American Diabetes

Association: national cross sectional study. Bmj, 369.

Mayer-Davis, E. J., Lawrence, J. M., Dabelea, D., Divers, J., Isom, S., Dolan, L., ... &

Wagenknecht, L. (2017). Incidence trends of type 1 and type 2 diabetes among youths,

2002–2012. N Engl J Med, 376, 1419-1429.

Munshi, M. N., Florez, H., Huang, E. S., Kalyani, R. R., Mupanomunda, M., Pandya, N., ... &

Haas, L. B. (2016). Management of diabetes in long-term care and skilled nursing facilities:

a position statement of the American Diabetes Association. Diabetes care, 39(2), 308-318.

Stevens, J. W., Khunti, K., Harvey, R., Johnson, M., Preston, L., Woods, H. B., ... & Goyder, E.

(2015). Preventing the progression to type 2 diabetes mellitus in adults at high risk: a

systematic review and network meta-analysis of lifestyle, pharmacological and surgical

interventions. Diabetes research and clinical practice, 107(3), 320-331.